LATEST ALERTS
Accurate and consistent CBD dosage will be vital for the industry as edible items become the biggest category of cannabinoid-derived products, experts predict
A murky legal situation and lack of government direction continue to hold back CBD in the UK and Europe, according to a keynote speaker at next month’s Europe CBD Expo in London
Recent studies show cannabinoids could help with sleep disorders, obsessive compulsive disorder (OCD), and cocaine addiction, while genetic research could help regulators delineate between cannabis strains
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up
The Cannabis Oil Company (TCOC) is hoping to raise £500,000 through crowdfunding to move into the vitamins and minerals markets, as well as funding clinical trials
International cannabis company Tilray has denied an accusation by the British Paediatric Neurological Association that it failed to provide sample products for testing
A meeting between the US FDA and members of the CBD industry provided the agency with plenty of information, but threw little light on the path it is likely to take
CBD continues to gain ground across sports in North America; with recent visibility in sports like rugby and baseball, and no general proscription against CBD use from the World Anti-Doping Code, it may be making headway into American football.
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.
Aurora Cannabis is to collaborate with Ultimate Fighting Championship (UFC), a mixed martial arts promotions company headquartered in Las Vegas, on studies of CBD’s possible usefulness in treating pain and inflammation and in recovery and wellbeing.
More and more British organisations are starting to develop a policy towards medical cannabis, but CBD guidelines appear to be lagging behind
The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis
Women are emerging as key players in the movement to promote medical CBD: starting their own businesses, campaigning for legalisation and creating networks for future empowerment
The US FDA is to hold a public hearing on 31st May on the safety of products containing cannabis or cannabis-derived compounds ― and stakeholders will be looking for a dividing line
Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be eased
Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme
A UK member of parliament has accused the president of a child healthcare organisation of lying to the parliamentary health and social care committee and dismissing the concerns of families
Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard
Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard
UK member of parliament Steve Brine, a supporter of medical cannabis, has resigned as under-secretary of state for public health over Brexit-related issues
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has announced plans to sell the product in nine states.
The Philippines moved one step closer to legalising cannabis for medical use when a bill was approved on its final reading, but its progress to law could be scuppered by opposition from president Rodrigo Duterte.
Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues
Obscure cannabinoids and even completely new ones could be produced synthetically from yeast, along with THC and CBD, according to scientists at the University of California in Berkeley
North American businesses are still investing millions in the CBD hemp market, despite the uncertainty generated by new legislation and clampdowns on retailers, with many US and Canadian firms acquiring nascent businesses
A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders
The French Medicines Agency (Agence Nationale du Médicament, ANSM) has issued a warning to consumers against buying illicit CBD products online
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan
The UK Food Standards Agency (FSA) will issue further guidance next week on the use of cannabinoids as novel food ingredients
The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner Scott Gottlieb
Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert
CBD shows promise for treating some medical conditions but the potential for interactions with other drugs is a cause for concern, as is poor quality control, according to a recent review of science in the field
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry
A growing domestic CBD consumer base and excellent potential for cannabis farming make Argentina an intriguing market despite regulatory ambiguity and differences in opinion between national and provincial authorities
Congressional politicians in Tennessee have been turning their attention to possible regulation of farming for CBD, while those in Georgia have been addressed by military veterans eager for CBD to be legalised
In our report looking at the regulations governing CBD in Taiwan, we find that CBD is a classified as a pharmaceutical product and the growing of cannabis plants for any purposes, and the addition of CBD to cosmetic products, is prohibited
Though Lloyds is a lesser name than Boots among UK pharmacy chains, its partnership with Sainsbury’s means it could be poised to dramatically expand the range of the supermarket’s CBD product offerings.
LloydsPharmacy started stocking a range of CBD products in October last year.
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned
The presence of CBD could render cannabis useless as a treatment for glaucoma, new research warns. Long-term use of the substance may even worsen one of the main risk factors for the eye disease
The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
Most European CBD oils label their CBD content correctly but comparatively few are accurate about THC, a study in the Czech Republic has found
Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research. The National Institute on Drug Abuse (NIDA) is probing for businesses that have the “in-house capability to act as a centralized source for acquisition and/or production, analysis, and distribution of cannabis and related materials for research purposes,” according to a federal notice.
The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD
Dr Sanjay Gupta, president of the American Pain Association (APA), has called on US insurance companies to cover CBD treatments for patients
Many cannabis strains marketed as distinct are in fact chemically much the same, but there may also be non-obvious differences and their effects on humans should not be judged purely on THC and CBD content, scientists say
Despite being Europe’s biggest hemp grower and reputedly its highest cannabis user, France has one of Europe’s most restrictive regulatory environments for cannabis use.
Comments invited by the FDA on the potential abuse and medical usefulness of CBD and other cannabis-derived substances will be submitted to the World Health Organization (WHO)
Prospects for CBD in Brazil depend hugely on the outcome of the forthcoming presidential election, in which the far right-wing candidate Jair Bolsonaro has emerged as a very strong favourite
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
